Remdesivir treatment in hospitalized patients affected by COVID‐19 pneumonia: A case‐control study

To date the optimal antiviral treatment against severe coronavirus disease 2019 (COVID‐19) has not been proven; remdesivir is a promising drug with in vitro activity against several viruses, but in COVID‐19 the clinical results are currently not definitive. In this retrospective observational study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Boglione, Lucio, Dodaro, Valentina, Meli, Giulia, Rostagno, Roberto, Poletti, Federica, Moglia, Roberta, Bianchi, Bianca, Esposito, Maria, Borrè, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088403/
https://www.ncbi.nlm.nih.gov/pubmed/35411627
http://dx.doi.org/10.1002/jmv.27768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088403/
https://www.ncbi.nlm.nih.gov/pubmed/35411627
http://dx.doi.org/10.1002/jmv.27768

Ejemplares similares